Name | Number of supported studies | Average coverage | |
---|---|---|---|
smooth muscle cell | 7 studies | 21% ± 3% | |
pericyte | 7 studies | 30% ± 11% | |
fibroblast | 4 studies | 23% ± 6% |
Insufficient scRNA-seq data for expression of NGF at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
kidney | 94% | 188.27 | 84 / 89 | 83% | 13.99 | 744 / 901 |
ovary | 100% | 810.22 | 180 / 180 | 69% | 3.21 | 297 / 430 |
adrenal gland | 76% | 97.39 | 196 / 258 | 92% | 6.31 | 212 / 230 |
thymus | 92% | 158.16 | 602 / 653 | 64% | 1.64 | 386 / 605 |
breast | 93% | 181.38 | 425 / 459 | 63% | 1.85 | 704 / 1118 |
uterus | 99% | 485.65 | 168 / 170 | 47% | 3.93 | 216 / 459 |
bladder | 95% | 251.52 | 20 / 21 | 47% | 2.44 | 238 / 504 |
prostate | 82% | 118.67 | 201 / 245 | 60% | 1.34 | 301 / 502 |
liver | 71% | 83.87 | 161 / 226 | 60% | 1.68 | 242 / 406 |
lung | 52% | 61.01 | 301 / 578 | 66% | 5.30 | 759 / 1155 |
esophagus | 67% | 99.90 | 974 / 1445 | 43% | 2.25 | 79 / 183 |
intestine | 76% | 154.97 | 731 / 966 | 26% | 0.85 | 136 / 527 |
blood vessel | 100% | 584.06 | 1334 / 1335 | 0% | 0 | 0 / 0 |
heart | 100% | 516.14 | 859 / 861 | 0% | 0 | 0 / 0 |
spleen | 98% | 165.02 | 235 / 241 | 0% | 0 | 0 / 0 |
adipose | 97% | 382.80 | 1173 / 1204 | 0% | 0 | 0 / 0 |
skin | 43% | 76.36 | 771 / 1809 | 32% | 1.06 | 152 / 472 |
stomach | 38% | 69.75 | 136 / 359 | 35% | 0.92 | 100 / 286 |
brain | 22% | 17.47 | 584 / 2642 | 46% | 1.33 | 327 / 705 |
pancreas | 4% | 2.94 | 14 / 328 | 62% | 1.84 | 111 / 178 |
tonsil | 0% | 0 | 0 / 0 | 36% | 2.37 | 16 / 45 |
muscle | 6% | 5.63 | 50 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 4% | 0.05 | 3 / 80 |
peripheral blood | 0% | 0.16 | 2 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0008285 | Biological process | negative regulation of cell population proliferation |
GO_0050804 | Biological process | modulation of chemical synaptic transmission |
GO_0007169 | Biological process | cell surface receptor protein tyrosine kinase signaling pathway |
GO_0021675 | Biological process | nerve development |
GO_0033138 | Biological process | positive regulation of peptidyl-serine phosphorylation |
GO_0010628 | Biological process | positive regulation of gene expression |
GO_0008625 | Biological process | extrinsic apoptotic signaling pathway via death domain receptors |
GO_0038180 | Biological process | nerve growth factor signaling pathway |
GO_0048812 | Biological process | neuron projection morphogenesis |
GO_0043388 | Biological process | positive regulation of DNA binding |
GO_0046579 | Biological process | positive regulation of Ras protein signal transduction |
GO_0045666 | Biological process | positive regulation of neuron differentiation |
GO_0043524 | Biological process | negative regulation of neuron apoptotic process |
GO_0005615 | Cellular component | extracellular space |
GO_0005576 | Cellular component | extracellular region |
GO_0005796 | Cellular component | Golgi lumen |
GO_0030425 | Cellular component | dendrite |
GO_0005829 | Cellular component | cytosol |
GO_0008021 | Cellular component | synaptic vesicle |
GO_0030424 | Cellular component | axon |
GO_0031904 | Cellular component | endosome lumen |
GO_0008289 | Molecular function | lipid binding |
GO_0005163 | Molecular function | nerve growth factor receptor binding |
GO_0008191 | Molecular function | metalloendopeptidase inhibitor activity |
GO_0008083 | Molecular function | growth factor activity |
GO_0005515 | Molecular function | protein binding |
Gene name | NGF |
Protein name | Beta-nerve growth factor (Beta-NGF) Nerve growth factor Beta-nerve growth factor |
Synonyms | NGFB |
Description | FUNCTION: Nerve growth factor is important for the development and maintenance of the sympathetic and sensory nervous systems . Extracellular ligand for the NTRK1 and NGFR receptors, activates cellular signaling cascades to regulate neuronal proliferation, differentiation and survival (Probable). The immature NGF precursor (proNGF) functions as a ligand for the heterodimeric receptor formed by SORCS2 and NGFR, and activates cellular signaling cascades that lead to inactivation of RAC1 and/or RAC2, reorganization of the actin cytoskeleton and neuronal growth cone collapse. In contrast to mature NGF, the precursor form (proNGF) promotes neuronal apoptosis (in vitro) (By similarity). Inhibits metalloproteinase-dependent proteolysis of platelet glycoprotein VI . Binds lysophosphatidylinositol and lysophosphatidylserine between the two chains of the homodimer. The lipid-bound form promotes histamine relase from mast cells, contrary to the lipid-free form (By similarity). . |
Accessions | ENST00000675637.2 ENST00000676038.2 ENST00000680116.1 A0A346FYQ1 ENST00000681124.1 P01138 ENST00000680752.1 A0A7P0TAZ6 ENST00000369512.3 ENST00000679806.1 ENST00000680540.1 |